Book contents
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Chapter 1 Introduction
- Chapter 2 What Are Club Drugs and NPS and Why Are They Important?
- Chapter 3 A Brief History of NPS Production and Distribution
- Chapter 4 Classification Framework for Club Drugs and NPS
- Chapter 5 The Clinical Challenge of Club Drugs and NPS
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Chapter 2 - What Are Club Drugs and NPS and Why Are They Important?
from Part I - Introduction
Published online by Cambridge University Press: 21 September 2020
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Chapter 1 Introduction
- Chapter 2 What Are Club Drugs and NPS and Why Are They Important?
- Chapter 3 A Brief History of NPS Production and Distribution
- Chapter 4 Classification Framework for Club Drugs and NPS
- Chapter 5 The Clinical Challenge of Club Drugs and NPS
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Summary
Drug use patterns over the last decade have been characterised by the emergence of a huge number of new illicit drugs. These drugs include so-called ‘club drugs’ and ‘novel’ or ‘new’ psychoactive substances (NPS), although neither term fully captures the range and complexity of the substances or the ways that they are used. There is also significant overlap between different drugs, but Figure 2.1 demonstrates how they can be considered as established drugs, established club drugs and NPS.
- Type
- Chapter
- Information
- Club Drugs and Novel Psychoactive SubstancesThe Clinician's Handbook, pp. 3 - 4Publisher: Cambridge University PressPrint publication year: 2020